Suchergebnisse - "Voss, Martin"

PubPharm (391)

1

Adjuvant Immunotherapy for Kidney Cancer - A New Strategy with New Challenges

enthalten in: The New England journal of medicine | 2024

von Voss, M. | Motzer, R.

2

Genomic ancestry in kidney cancer : Correlations with clinical and molecular features

enthalten in: Cancer | 2024

von Kotecha, R. | Knezevic, A. | Arora, K. | +14

3

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma

enthalten in: Urologic oncology | 2024

von Reese, S. | Eismann, L. | White, C. | +15

4

ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection

enthalten in: Cardiovascular research | 2024

von Bredow, C. | Thery, F. | Wirth, E. | +20

5

Genomic ancestry in kidney cancer : Correlations with clinical and molecular features

enthalten in: Cancer | 2024

von Kotecha, R. | Knezevic, A. | Arora, K. | +14

6

LITESPARK-012 : pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma

enthalten in: Future oncology (London, England) | 2023

von Choueiri, T. | Powles, T. | Voss, M. | +6

7

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

enthalten in: European urology oncology | 2023

von Kotecha, R. | Doshi, S. | Knezevic, A. | +16

8

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

enthalten in: European urology focus | 2023

von Hahn, A. | Kotecha, R. | Viscuse, P. | +17

9

Reply by Authors

enthalten in: The Journal of urology | 2023

von Reese, S. | Khaleel, S. | Silagy, A. | +11

10

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy

enthalten in: The Journal of urology | 2023

von Reese, S. | Khaleel, S. | Silagy, A. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]